205 related articles for article (PubMed ID: 10711788)
1. Prooxidant and antioxidant properties of Trolox C, analogue of vitamin E, in oxidation of low-density lipoprotein.
Albertini R; Abuja PM
Free Radic Res; 1999 Mar; 30(3):181-8. PubMed ID: 10711788
[TBL] [Abstract][Full Text] [Related]
2. Fibrinogen is a co-antioxidant that supplements the vitamin E analog trolox in a model system.
Abudu N; Miller JJ; Levinson SS
Free Radic Res; 2006 Mar; 40(3):321-31. PubMed ID: 16484048
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of antioxidant activity of epigallocatechin gallate in biphasic model systems in vitro.
Hu C; Kitts DD
Mol Cell Biochem; 2001 Feb; 218(1-2):147-55. PubMed ID: 11330830
[TBL] [Abstract][Full Text] [Related]
4. Absence of an effect of vitamin E on protein and lipid radical formation during lipoperoxidation of LDL by lipoxygenase.
Ganini D; Mason RP
Free Radic Biol Med; 2014 Nov; 76():61-8. PubMed ID: 25091900
[TBL] [Abstract][Full Text] [Related]
5. A comparison between the antioxidant and peroxynitrite-scavenging functions of the vitamin E metabolites alpha- and gamma-carboxyethyl-6-hydroxychromans.
Galli F; Piroddi M; Lannone A; Pagliarani S; Tomasi A; Floridi A
Int J Vitam Nutr Res; 2004 Sep; 74(5):362-73. PubMed ID: 15628675
[TBL] [Abstract][Full Text] [Related]
6. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation.
Neuzil J; Stocker R
J Biol Chem; 1994 Jun; 269(24):16712-9. PubMed ID: 8206992
[TBL] [Abstract][Full Text] [Related]
7. Antioxidant and prooxidant activity of alpha-tocopherol in human plasma and low density lipoprotein.
Kontush A; Finckh B; Karten B; Kohlschütter A; Beisiegel U
J Lipid Res; 1996 Jul; 37(7):1436-48. PubMed ID: 8827516
[TBL] [Abstract][Full Text] [Related]
8. Unconjugated bilirubin inhibits the oxidation of human low density lipoprotein better than Trolox.
Wu TW; Fung KP; Yang CC
Life Sci; 1994; 54(25):P477-81. PubMed ID: 8201841
[TBL] [Abstract][Full Text] [Related]
9. When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid.
Bagnati M; Perugini C; Cau C; Bordone R; Albano E; Bellomo G
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):143-52. PubMed ID: 10229669
[TBL] [Abstract][Full Text] [Related]
10. alpha-Tocopherol and trolox block the early intracellular events (TBARS and calcium rises) elicited by oxidized low density lipoproteins in cultured endothelial cells.
Mabile L; Fitoussi G; Periquet B; Schmitt A; Salvayre R; Nègre-Salvayre A
Free Radic Biol Med; 1995 Aug; 19(2):177-87. PubMed ID: 7649489
[TBL] [Abstract][Full Text] [Related]
11. Protection of low density lipoprotein oxidation by the antioxidant agent IRFI005, a new synthetic hydrophilic vitamin E analogue.
Iuliano L; Pedersen JZ; Camastra C; Bello V; Ceccarelli S; Violi F
Free Radic Biol Med; 1999 Apr; 26(7-8):858-68. PubMed ID: 10232829
[TBL] [Abstract][Full Text] [Related]
12. Effects of antioxidants on the oxidative susceptibility of low-density lipoprotein.
Hirano R; Kondo K; Iwamoto T; Igarashi O; Itakura H
J Nutr Sci Vitaminol (Tokyo); 1997 Aug; 43(4):435-44. PubMed ID: 9328862
[TBL] [Abstract][Full Text] [Related]
13. The importance of lipid solubility in antioxidants and free radical generating systems for determining lipoprotein proxidation.
Massaeli H; Sobrattee S; Pierce GN
Free Radic Biol Med; 1999 Jun; 26(11-12):1524-30. PubMed ID: 10401618
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of copper- and peroxyl radical-induced LDL lipid oxidation by ebselen: antioxidant actions in addition to hydroperoxide-reducing activity.
Lass A; Witting P; Stocker R; Esterbauer H
Biochim Biophys Acta; 1996 Sep; 1303(2):111-8. PubMed ID: 8856040
[TBL] [Abstract][Full Text] [Related]
15. Hydroxyl radical formation from Cu(II)-trolox mixtures: insights into the pro-oxidant properties of alpha-tocopherol.
Burkitt MJ; Milne L
FEBS Lett; 1996 Jan; 379(1):51-4. PubMed ID: 8566228
[TBL] [Abstract][Full Text] [Related]
16. Ascorbic acid oxidation product(s) protect human low density lipoprotein against atherogenic modification. Anti- rather than prooxidant activity of vitamin C in the presence of transition metal ions.
Retsky KL; Freeman MW; Frei B
J Biol Chem; 1993 Jan; 268(2):1304-9. PubMed ID: 8419332
[TBL] [Abstract][Full Text] [Related]
17. Phenolic content of various beverages determines the extent of inhibition of human serum and low-density lipoprotein oxidation in vitro: identification and mechanism of action of some cinnamic acid derivatives from red wine.
Abu-Amsha R; Croft KD; Puddey IB; Proudfoot JM; Beilin LJ
Clin Sci (Lond); 1996 Oct; 91(4):449-58. PubMed ID: 8983870
[TBL] [Abstract][Full Text] [Related]
18. Mangostin inhibits the oxidative modification of human low density lipoprotein.
Williams P; Ongsakul M; Proudfoot J; Croft K; Beilin L
Free Radic Res; 1995 Aug; 23(2):175-84. PubMed ID: 7581813
[TBL] [Abstract][Full Text] [Related]
19. Prooxidant and antioxidant activity of vitamin E analogues and troglitazone.
Tafazoli S; Wright JS; O'Brien PJ
Chem Res Toxicol; 2005 Oct; 18(10):1567-74. PubMed ID: 16533021
[TBL] [Abstract][Full Text] [Related]
20. A high concentration of melatonin inhibits in vitro LDL peroxidation but not oxidized LDL toxicity toward cultured endothelial cells.
Walters-Laporte E; Furman C; Fouquet S; Martin-Nizard F; Lestavel S; Gozzo A; Lesieur D; Fruchart JC; Duriez P; Teissier E
J Cardiovasc Pharmacol; 1998 Oct; 32(4):582-92. PubMed ID: 9781926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
